Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Supernus Pharmaceuticals (SUPN)
NASDAQ:SUPN
RESEARCH TOOLSreports
Supernus Pharmaceuticals (SUPN) Ownership - Who Owns Supernus Pharmaceuticals?
448 Followers
Supernus Pharmaceuticals (SUPN) Ownership Overview
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 17, 2023 | Frederick Hudson Director | Sold | $259151 |
| Nov 16, 2023 | Mottola Frank Svp, Quality, Gmp, Ops, It | Sold | $31224 |
| Sep 01, 2023 | Tami Tillotson Martin Sr. V.p., Regulatory Affairs | Sold | $259200 |
| Mar 16, 2023 | Mottola Frank Svp, Quality, Gmp, Ops, It | Sold | $171984 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $516937 | |
| Sep 30, 2023 | Bought | $3213255 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,417,239.00 | Institution | 11.75% | 176,987,451.62 | |
| 5,267,160.00 | Institution | 9.64% | 145,268,272.80 | |
| 4,545,490.00 | Institution | 8.32% | 125,364,614.20 | |
| 3,820,625.00 | Insider | 6.99% | 105,372,837.50 | |
| 3,820,625.00 | Insider | 6.99% | 105,372,837.50 | |
| 1,999,569.00 | Institution | 3.66% | 55,148,113.02 | |
| 1,906,413.00 | Insider | 3.49% | 52,578,870.54 | |
| 1,559,876.00 | Institution | 2.86% | 43,021,380.08 | |
| 923,317.00 | Institution | 1.69% | 25,465,082.86 | |
| 894,425.00 | Institution | 1.64% | 24,668,241.50 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,545,490.00 | Institution | 8.32% | 125,364,614.20 | |
| 1,999,569.00 | Institution | 3.66% | 55,148,113.02 | |
| 1,559,876.00 | Institution | 2.86% | 43,021,380.08 | |
| 894,425.00 | Institution | 1.64% | 24,668,241.50 | |
| 767,123.00 | Institution | 1.40% | 21,157,252.34 | |
| 751,439.00 | Institution | 1.38% | 20,724,687.62 | |
| 570,000.00 | Institution | 1.04% | 15,720,600.00 | |
| 525,962.00 | Institution | 0.96% | 14,506,031.96 | |
| 502,552.00 | Institution | 0.92% | 13,860,384.16 | |
| 426,926.00 | Institution | 0.78% | 11,774,619.08 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,634,450.00 | Institution | 6.65% | 99,038,762.50 | |
| 1,634,487.00 | Institution | 2.99% | 38,982,515.00 | |
| 1,185,970.00 | Institution | 2.17% | 32,317,682.50 | |
| 1,337,917.00 | Institution | 2.45% | 31,909,320.00 | |
| 775,938.00 | Institution | 1.42% | 18,506,121.00 | |
| 555,332.00 | Institution | 1.02% | 15,132,797.00 | |
| 454,567.00 | Institution | 0.83% | 12,386,950.75 | |
| 430,977.00 | Institution | 0.79% | 11,744,123.25 | |
| 463,158.00 | Institution | 0.85% | 11,046,318.00 | |
| 372,777.00 | Institution | 0.68% | 8,890,731.00 |
FAQ
Who Owns Supernus Pharmaceuticals (SUPN)?
Currently, no data Available
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by institutional investors?
Currently, no data Available
What percentage of Supernus Pharmaceuticals (SUPN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Supernus Pharmaceuticals (SUPN)?
iShares owns the most shares of Supernus Pharmaceuticals (SUPN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.